144 related articles for article (PubMed ID: 20452911)
21. Measuring patient satisfaction in the pharmacy specialty immunization clinic: a pharmacist-run Immunization Clinic at the Veterans Affairs San Diego Healthcare System.
Bounthavong M; Christopher ML; Mendes MA; Foster EB; Johns ST; Lim L; Rubin LM; Patel JJ; Stewart AG
Int J Pharm Pract; 2010 Apr; 18(2):100-7. PubMed ID: 20441119
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs medical centers: an update.
Cone SM; Brown MC; Stambaugh RL
Am J Health Syst Pharm; 2008 Apr; 65(7):631-5. PubMed ID: 18359970
[TBL] [Abstract][Full Text] [Related]
23. Pharmacist management of a hyperlipidemia clinic.
Furmaga EM
Am J Hosp Pharm; 1993 Jan; 50(1):91-5. PubMed ID: 8427286
[TBL] [Abstract][Full Text] [Related]
24. Implementing an opioid risk assessment telephone clinic: Outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014-March 31, 2015.
Jacobs SC; Son EK; Tat C; Chiao P; Dulay M; Ludwig A
Subst Abus; 2016; 37(1):15-9. PubMed ID: 26675444
[TBL] [Abstract][Full Text] [Related]
25. Gender differences in achieving optimal lipid goals in patients with coronary artery disease.
Victor BM; Teal V; Ahedor L; Karalis DG
Am J Cardiol; 2014 May; 113(10):1611-5. PubMed ID: 24698458
[TBL] [Abstract][Full Text] [Related]
26. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels.
Ali F; Laurin MY; Larivière C; Tremblay D; Cloutier D
Can J Clin Pharmacol; 2003; 10(3):101-6. PubMed ID: 14506507
[TBL] [Abstract][Full Text] [Related]
27. Active Lipid Management In Coronary Artery Disease (ALMICAD) study.
Khanal S; Obeidat O; Hudson MP; Al-Mallah M; Bloome M; Lu M; Greenbaum AB; Kugelmass AD; Weaver WD
Am J Med; 2007 Aug; 120(8):734.e11-7. PubMed ID: 17679135
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two different models of anticoagulation management services with usual medical care.
Rudd KM; Dier JG
Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
[TBL] [Abstract][Full Text] [Related]
29. Pharmacist-managed telephone clinic review of antidementia medication effectiveness.
Oderda L; Holman C; Nichols B; Rupper R; Bair B; Hoffman M; Hicken B
Consult Pharm; 2011 Apr; 26(4):264-73. PubMed ID: 21486737
[TBL] [Abstract][Full Text] [Related]
30. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
31. Non-attendance at secondary prevention clinics: the effect on lipid management.
McLeod AL; Brooks L; Taylor V; Wylie A; Currie PF; Dewhurst NG
Scott Med J; 2005 May; 50(2):54-6. PubMed ID: 15977514
[TBL] [Abstract][Full Text] [Related]
32. Impact of live medication therapy management on cholesterol values in patients with cardiovascular disease.
Thumar R; Zaiken K
J Am Pharm Assoc (2003); 2014; 54(5):526-9. PubMed ID: 25216882
[TBL] [Abstract][Full Text] [Related]
33. Comparison of an intensive pharmacist-managed telephone clinic with standard of care for tobacco cessation in a veteran population.
Chen T; Kazerooni R; Vannort EM; Nguyen K; Nguyen S; Harris J; Bounthavong M
Health Promot Pract; 2014 Jul; 15(4):512-20. PubMed ID: 24231631
[TBL] [Abstract][Full Text] [Related]
34. Time trends of gender-based differences in lipid goal attainments during secondary prevention of coronary artery disease: results of a 5-year survey.
Singh M; Chin SH; Crothers D; Giles P; Al-Allaf K; Khan JM
Am J Ther; 2013; 20(6):613-7. PubMed ID: 23344096
[TBL] [Abstract][Full Text] [Related]
35. Role of a pharmacist in a seizure clinic.
Kootsikas ME; Hayes G; Thompson JF; Perlman S; Brinkman JH
Am J Hosp Pharm; 1990 Nov; 47(11):2478-82. PubMed ID: 2278258
[TBL] [Abstract][Full Text] [Related]
36. Integration of a Clinical Pharmacist into an Interdisciplinary Palliative Care Outpatient Clinic.
DiScala SL; Onofrio S; Miller M; Nazario M; Silverman M
Am J Hosp Palliat Care; 2017 Nov; 34(9):814-819. PubMed ID: 27418599
[TBL] [Abstract][Full Text] [Related]
37. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
38. Improving care to patients with ischemic heart disease: experiences in a single network of the Veterans Health Administration.
Pineros SL; Sales AE; Li YF; Sharp ND
Worldviews Evid Based Nurs; 2004; 1 Suppl 1():S33-40. PubMed ID: 17129333
[TBL] [Abstract][Full Text] [Related]
39. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):109-14. PubMed ID: 21293326
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management.
Machado M; Nassor N; Bajcar JM; Guzzo GC; Einarson TR
Ann Pharmacother; 2008 Sep; 42(9):1195-207. PubMed ID: 18682540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
